Covid-19 Infection and the Host Genetic Predisposition: Does it Exist?

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	VAŠKŮ Anna
Year of publication	2020
Type	Article in Periodical
Magazine / Source	Physiological research
MU Faculty or unit	Faculty of Medicine
Citation
Web	http://www.biomed.cas.cz/physiolres/pdf/2020/69_511.pdf
Doi	http://dx.doi.org/10.33549/physiolres.934504
Keywords	ACE2 polymorphisms; COVID 19; Cardiovascular disease; Diabetes mellitus; Hyperlipoproteinemia; Pharmacogenetics
Description	Knowledge of genomic interindividual variability could help us to explain why different manifestation of clinical severity of Covid-19 infection as well as modified pharmacogenetic relations can be expected during this pandemic condition.
Related projects:	Asociace polymorfismů v genech pro metaloproteinázy, jejich inhibitory, ACE, ACE2 a apelinu s centrálním pulsním tlakem u pacientů s ischemickou chorobou srdeční